Dr Alan Tenaglia, MD | |
3099 N Civic Center Plz, Scottsdale, AZ 85251-6903 | |
(480) 945-3535 | |
(480) 994-8179 |
Full Name | Dr Alan Tenaglia |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 39 Years |
Location | 3099 N Civic Center Plz, Scottsdale, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215976550 | NPI | - | NPPES |
AZ0156300 | Other | AZ | BCBS ARIZONA |
P00255520 | Other | AZ | RAILROAD MEDICARE |
4257349 | Other | AZ | AETNA |
2152114 | Other | AZ | CIGNA |
2Z3627 | Other | AZ | HEALTHNET |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 34535 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Scottsdale Osborn Medical Center | Scottsdale, AZ | Hospital |
Honorhealth Scottsdale Shea Medical Center | Scottsdale, AZ | Hospital |
John C. Lincoln North Mountain Hospital | Phoenix, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Honorhealth Ambulatory | 5991603110 | 406 |
News Archive
ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.
Improvements to the technology infrastructure for researching and developing new biopharmaceuticals would be expected to save the industry hundreds of millions of dollars annually, according to a new economic study sponsored by the National Institute of Standards and Technology (NIST).
Using nanoparticles to engineer a special drug, a team of researchers from McGovern Medical School at The University of Texas Health Science Center at Houston has demonstrated in pre-clinical trials a new way to both reduce preterm birth and avoid the risks of medication in pregnancy to unborn babies.
A first of its kind benchmarking survey was used to evaluate the state of inpatient psychiatry settings and services for youth at hospitals across Ontario, as published today in the Journal of the Canadian Academy of Child and Adolescent Psychiatry. On average, the province's services are comparable to other settings internationally, helping youth with the most severe and complex mental health problems, but also show similar signs of inconsistency across settings in the types and quality of inpatient care.
› Verified 8 days ago
Entity Name | Honorhealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801092564 PECOS PAC ID: 1456258607 Enrollment ID: O20031216000350 |
News Archive
ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.
Improvements to the technology infrastructure for researching and developing new biopharmaceuticals would be expected to save the industry hundreds of millions of dollars annually, according to a new economic study sponsored by the National Institute of Standards and Technology (NIST).
Using nanoparticles to engineer a special drug, a team of researchers from McGovern Medical School at The University of Texas Health Science Center at Houston has demonstrated in pre-clinical trials a new way to both reduce preterm birth and avoid the risks of medication in pregnancy to unborn babies.
A first of its kind benchmarking survey was used to evaluate the state of inpatient psychiatry settings and services for youth at hospitals across Ontario, as published today in the Journal of the Canadian Academy of Child and Adolescent Psychiatry. On average, the province's services are comparable to other settings internationally, helping youth with the most severe and complex mental health problems, but also show similar signs of inconsistency across settings in the types and quality of inpatient care.
› Verified 8 days ago
Entity Name | Honorhealth Ambulatory |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407050917 PECOS PAC ID: 5991603110 Enrollment ID: O20071005000449 |
News Archive
ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.
Improvements to the technology infrastructure for researching and developing new biopharmaceuticals would be expected to save the industry hundreds of millions of dollars annually, according to a new economic study sponsored by the National Institute of Standards and Technology (NIST).
Using nanoparticles to engineer a special drug, a team of researchers from McGovern Medical School at The University of Texas Health Science Center at Houston has demonstrated in pre-clinical trials a new way to both reduce preterm birth and avoid the risks of medication in pregnancy to unborn babies.
A first of its kind benchmarking survey was used to evaluate the state of inpatient psychiatry settings and services for youth at hospitals across Ontario, as published today in the Journal of the Canadian Academy of Child and Adolescent Psychiatry. On average, the province's services are comparable to other settings internationally, helping youth with the most severe and complex mental health problems, but also show similar signs of inconsistency across settings in the types and quality of inpatient care.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Alan Tenaglia, MD 3099 N Civic Center Plz, Scottsdale, AZ 85251-6903 Ph: (480) 945-3535 | Dr Alan Tenaglia, MD 3099 N Civic Center Plz, Scottsdale, AZ 85251-6903 Ph: (480) 945-3535 |
News Archive
ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.
Improvements to the technology infrastructure for researching and developing new biopharmaceuticals would be expected to save the industry hundreds of millions of dollars annually, according to a new economic study sponsored by the National Institute of Standards and Technology (NIST).
Using nanoparticles to engineer a special drug, a team of researchers from McGovern Medical School at The University of Texas Health Science Center at Houston has demonstrated in pre-clinical trials a new way to both reduce preterm birth and avoid the risks of medication in pregnancy to unborn babies.
A first of its kind benchmarking survey was used to evaluate the state of inpatient psychiatry settings and services for youth at hospitals across Ontario, as published today in the Journal of the Canadian Academy of Child and Adolescent Psychiatry. On average, the province's services are comparable to other settings internationally, helping youth with the most severe and complex mental health problems, but also show similar signs of inconsistency across settings in the types and quality of inpatient care.
› Verified 8 days ago
Russell S Ruzich, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Dr. Paul Joseph Schenk, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 11230 E Beck Ln, Scottsdale, AZ 85255 Phone: 480-502-9457 | |
Dr. Musab Sultan Hommos, M.B., B.S. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Soyoung Park, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10460 N 92nd St Ste 300, Scottsdale, AZ 85258 Phone: 480-323-1573 Fax: 480-323-1375 | |
Dr. Michael Edward Killian, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: Mayo Clinic 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 085-120-6856 | |
Hesham Mubarak Ibrahim Moh Abdalla, M.B.B.S. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 13400 E Shea Blvd, Scottsdale, AZ 85259 Phone: 480-301-8000 | |
Kianoush Cheybani, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9590 E Ironwood Square Dr, Ste 125, Scottsdale, AZ 85258 Phone: 480-455-3000 Fax: 866-819-6115 |